This study did not specifically determine the number of dendritic cells within the TME or TDLNs, but the IHC study showed that there was an increase in the number of one of the markers of antigen‐presenting cells, CD86, in both Panc02 and KPC tumours excised from mice treated with Abraxane, either alone or combined with hIL15‐ABD (Figure 4O). Here, CD86 is linked to neoplasm.